logo

VKTX Stock: Exploring Viking Therapeutics Inc’s Growth

Viking Therapeutics Inc’s stock has had a calm market performance. The 1-year high for the company’s stock was $99.41 on 02/28/24, and the lowest price during the same period was recorded at $8.28 on 10/26/23.

52-week price history of VKTX Stock

Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Viking Therapeutics Inc’s current trading price is -33.41% away from its 52-week high, while its distance from the 52-week low is 699.46%. The stock’s price range for this period has remained between $8.28 and $99.41. The Healthcare sector company’s shares managed to surpass a trading volume of around 1.02 million for the day, which was noticeably lower compared to the shares’ average daily volume of 6.4 million over the last three months.

Financial Performance and Market Capitalization

Viking Therapeutics Inc (VKTX) has experienced a quarterly rise of 208.60% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 7.24B and boasts a workforce of 27 employees.

Moving average and trading volume data

Based on Barchart.com data, the company’s moving average over the 100-day period was 43.58, with a change in price of +53.66. Similarly, Viking Therapeutics Inc recorded 5,186,551 in trading volume during the last 100 days, posting a change of +453.56%.

VKTX Debt-to-equity ratio analysis

The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for VKTX stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.

VKTX Stock Stochastic Average

As of today, the raw stochastic average of Viking Therapeutics Inc over the past 50 days is 51.25%. This is a increase compared to the raw stochastic average of the last 20 days, which was recorded at 16.33%. Additionally, the Stochastic %K and %D values for the company were 12.12% and 8.68%, respectively, over the past 20 days.

VKTX Stock Price Performance Analysis

Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. Until today this year the stock’s price performance recorded an increase of 255.70%. However, over the last six months, the performance has been weaker by 537.72%. The price of VKTX decreased -4.33% over the last 30 days. And in the last five days, it has fallen by -0.41%.